Anika Therapeutics Stock Forecast - Day Median Price

ANIK Stock  USD 17.20  0.23  1.36%   
Anika Stock Forecast is based on your current time horizon. Although Anika Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Anika Therapeutics' systematic risk associated with finding meaningful patterns of Anika Therapeutics fundamentals over time.
  
At this time, Anika Therapeutics' Inventory Turnover is quite stable compared to the past year. Receivables Turnover is expected to rise to 7.30 this year, although the value of Payables Turnover will most likely fall to 6.22. . The value of Common Stock Shares Outstanding is expected to slide to about 12.7 M. Net Loss is expected to rise to about (16.2 M) this year.
Anika Therapeutics has current Day Median Price of 17.36. Median Price is the statistical median of an asset price for a given trading period.
Check Anika Therapeutics VolatilityBacktest Anika TherapeuticsInformation Ratio  

Anika Therapeutics Trading Date Momentum

On November 26 2024 Anika Therapeutics was traded for  17.20  at the closing time. The top price for the day was 17.63  and the lowest listed price was  17.09 . There was no trading activity during the period 0.0. Lack of trading volume on November 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.64% .
The median price is the midpoint of the trading periods range.
Compare Anika Therapeutics to competition

Other Forecasting Options for Anika Therapeutics

For every potential investor in Anika, whether a beginner or expert, Anika Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Anika Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Anika. Basic forecasting techniques help filter out the noise by identifying Anika Therapeutics' price trends.

Anika Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anika Therapeutics stock to make a market-neutral strategy. Peer analysis of Anika Therapeutics could also be used in its relative valuation, which is a method of valuing Anika Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Anika Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Anika Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Anika Therapeutics' current price.

Anika Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Anika Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anika Therapeutics shares will generate the highest return on investment. By undertsting and applying Anika Therapeutics stock market strength indicators, traders can identify Anika Therapeutics entry and exit signals to maximize returns.

Anika Therapeutics Risk Indicators

The analysis of Anika Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Anika Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting anika stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Anika Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Anika Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Anika Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Anika Therapeutics Stock:
Check out Historical Fundamental Analysis of Anika Therapeutics to cross-verify your projections.
For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.51)
Earnings Share
(6.73)
Revenue Per Share
11.139
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.04)
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.